US revokes breast cancer drug's licence 25 Nov 2011 0 comments US health officials have revoked the authorisation of bevacizumab for breast cancer treatment, saying the drug has "not been shown to be safe and effective for that use".
Information tool for early menopause 25 Nov 2011 0 comments Australian experts have come up with an information tool to 'fill a gap' in treating breast cancer in women with early menopause.
Touted benefits of pre-op MRI remain unproven 18 Nov 2011 0 comments There is little evidence that pre-operative MRI improves outcomes for breast cancer patients, according to a new systematic review.
Brain impairments linked to cancer and chemotherapy 18 Nov 2011 0 comments New research sheds light on why some breast cancer patients experience neurological impairments, with evidence certain areas of the brain are particularly vulnerable to chemotherapy.
Video conferencing effective in genetic counselling 26 Aug 2011 0 comments Genetic counselling for hereditary breast and ovarian cancer via video-conferencing in rural and remote areas may be less suitable for certain groups of women, Australian research shows.
Falling mortality not down to screening 29 Jul 2011 0 comments Falling breast cancer death rates in Europe have little to do with breast screening but may be explained by better treatment and health systems, researchers report.
PBS changes rules on lapatinib prescribing 10 Dec 2010 0 comments The Pharmaceutical Benefits Scheme (PBS) has amended the rules on anti-solid tumour drug lapatinib (Tykerb) from this month, allowing women with HER2-positive secondary breast cancer to return to…
Monitor bone health during anti-oestrogen treatment for breast cancer 10 Dec 2010 0 comments The need to carefully monitor bone health and treat bone loss in women receiving anti-oestrogen therapy for breast cancer has been emphasised by a recent review in the Journal of Clinical…
Echo preferred for pre-chemotherapy cardiac assessment 10 Dec 2010 0 comments Echocardiograms in cancer patients prior to cardiotoxic chemotherapy provide more useful clinical information than the more commonly-used gated blood pool scans, according to Australian research.
Consider trastuzumab for small breast tumours 3 Dec 2010 0 comments British oncologists are recommending that adjuvant trastuzumab be considered for patients with small HER2-positive breast tumours in light of "strong circumstantial evidence" supporting its use.
